These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20090941)

  • 21. Potent in vitro and in vivo antitumor activity of interleukin-4-conjugated Pseudomonas exotoxin against human biliary tract carcinoma.
    Ishige K; Shoda J; Kawamoto T; Matsuda S; Ueda T; Hyodo I; Ohkohchi N; Puri RK; Kawakami K
    Int J Cancer; 2008 Dec; 123(12):2915-22. PubMed ID: 18798553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGF ligand fused to truncated Pseudomonas aeruginosa exotoxin A specifically targets and inhibits EGFR‑positive cancer cells.
    Hashimi SM; Grant B; Alqurashi N; Alowaidi F; Wei MQ
    Oncol Rep; 2018 Nov; 40(5):2690-2697. PubMed ID: 30226622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to pseudomonas exotoxin.
    Murad GJ; Walbridge S; Morrison PF; Garmestani K; Degen JW; Brechbiel MW; Oldfield EH; Lonser RR
    Clin Cancer Res; 2006 May; 12(10):3145-51. PubMed ID: 16707614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Target-specific cytotoxic activity of recombinant immunotoxin scFv(MUC1)-ETA on breast carcinoma cells and primary breast tumors.
    Singh R; Samant U; Hyland S; Chaudhari PR; Wels WS; Bandyopadhyay D
    Mol Cancer Ther; 2007 Feb; 6(2):562-9. PubMed ID: 17308054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa.
    Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV
    Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterizations of a novel recombinant scFv antibody against exotoxin A of Pseudomonas aeruginosa.
    Shadman Z; Farajnia S; Pazhang M; Tohidkia M; Rahbarnia L; Najavand S; Toraby S
    BMC Infect Dis; 2021 Mar; 21(1):300. PubMed ID: 33761869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fusion protein vaccine by domains of bacterial exotoxin linked with a tumor antigen generates potent immunologic responses and antitumor effects.
    Liao CW; Chen CA; Lee CN; Su YN; Chang MC; Syu MH; Hsieh CY; Cheng WF
    Cancer Res; 2005 Oct; 65(19):9089-98. PubMed ID: 16204084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients.
    Onda M; Nagata S; FitzGerald DJ; Beers R; Fisher RJ; Vincent JJ; Lee B; Nakamura M; Hwang J; Kreitman RJ; Hassan R; Pastan I
    J Immunol; 2006 Dec; 177(12):8822-34. PubMed ID: 17142785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudomonas exotoxin: recombinant conjugates as therapeutic agents.
    FitzGerald DJ; Pastan I
    Biochem Soc Trans; 1992 Nov; 20(4):731-4. PubMed ID: 1487051
    [No Abstract]   [Full Text] [Related]  

  • 30. Designing the furin-cleavable linker in recombinant immunotoxins based on Pseudomonas exotoxin A.
    Weldon JE; Skarzynski M; Therres JA; Ostovitz JR; Zhou H; Kreitman RJ; Pastan I
    Bioconjug Chem; 2015 Jun; 26(6):1120-8. PubMed ID: 25997032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A.
    Kaplan G; Lee F; Onda M; Kolyvas E; Bhardwaj G; Baker D; Pastan I
    Toxins (Basel); 2016 Jul; 8(8):. PubMed ID: 27463727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HER2-Specific Targeted Toxin DARPin-LoPE: Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model.
    Sokolova EA; Shilova ON; Kiseleva DV; Schulga AA; Balalaeva IV; Deyev SM
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary inflammation induced by Pseudomonas aeruginosa lipopolysaccharide, phospholipase C, and exotoxin A: role of interferon regulatory factor 1.
    Wieland CW; Siegmund B; Senaldi G; Vasil ML; Dinarello CA; Fantuzzi G
    Infect Immun; 2002 Mar; 70(3):1352-8. PubMed ID: 11854220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of protective properties of recombinant atoxic form of exotoxin A and recombinant outer membrane protein F of Pseudomonas aeruginosa].
    Mikhaĭlova NA; Vertiev IuV; Kaloshin AA; Isakov MA
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):39-44. PubMed ID: 20464999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal immunization strategy to impede pilin-mediated binding of Pseudomonas aeruginosa to airway epithelial cells.
    Hsieh JC; Tham DM; Feng W; Huang F; Embaie S; Liu K; Dean D; Hertle R; Fitzgerald DJ; Mrsny RJ
    Infect Immun; 2005 Nov; 73(11):7705-17. PubMed ID: 16239575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triphenylmethyl derivatives enhances the anticancer effect of immunotoxins.
    Risberg K; Guldvik IJ; Palchaudhuri R; Xi Y; Ju J; Fodstad O; Hergenrother PJ; Andersson Y
    J Immunother; 2011 Jun; 34(5):438-47. PubMed ID: 21577141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudomonas exotoxin--immunotoxins.
    FitzGerald DJ; Willingham MC; Pastan I
    Cancer Treat Res; 1988; 37():161-73. PubMed ID: 2908624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of Immunotoxins Containing
    Mazor R; Pastan I
    Front Immunol; 2020; 11():1261. PubMed ID: 32695104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer.
    Pai LH; Bookman MA; Ozols RF; Young RC; Smith JW; Longo DL; Gould B; Frankel A; McClay EF; Howell S
    J Clin Oncol; 1991 Dec; 9(12):2095-103. PubMed ID: 1960550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction, expression, and characterization of an anti-tumor immunotoxin containing the human anti-c-Met single-chain antibody and PE38KDEL.
    Liu Z; Feng Z; Zhu X; Xu W; Zhu J; Zhang X; Fan Z; Ji G
    Immunol Lett; 2013 Jan; 149(1-2):30-40. PubMed ID: 23026237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.